A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2022; you can also visit the original URL.
The file type is application/pdf
.
RHEUMATOID ARTHRITIS: TOO HIGH A PRICE FOR CORTICOSTEROIDS
2017
Romanian Journal of Rheumatology
Rheumatoid arthritis (RA) is a chronic rheumatic systemic disease characterized by proliferative synovitis, with cartilage and bone destruction, affecting joint functions with serious effects on the patient's quality of life. Heterogenicity of the disease, complications and comorbidities are important in choosing the treatment. Corticosteroids as treatment of RA represent an important issue both through their positive effects on inflammation and its consequences and through their negative
doi:10.37897/rjr.2017.2.6
doaj:79ea10bfd9c945709c3b803011c5c501
fatcat:b3nwoyptgjdejny2iqzulclyv4